Kwang Dong Pharmaceutical Co., Ltd.
Kwang Dong Pharmaceutical Co., Ltd., a prominent player in the pharmaceutical industry, is headquartered in South Korea (KR) and operates extensively across Asia. Founded in 1963, the company has established itself as a leader in the development and manufacturing of a diverse range of healthcare products, including over-the-counter medications, herbal remedies, and nutritional supplements. Kwang Dong is renowned for its commitment to quality and innovation, with core products that cater to various health needs, setting them apart in a competitive market. The company has achieved significant milestones, including advancements in research and development, which have solidified its market position. With a focus on enhancing health and well-being, Kwang Dong continues to make notable contributions to the pharmaceutical landscape, earning recognition for its dedication to excellence and customer satisfaction.
DitchCarbon Score
How does Kwang Dong Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Kwang Dong Pharmaceutical Co., Ltd.'s score of 22 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Kwang Dong Pharmaceutical Co., Ltd.'s reported carbon emissions
Kwang Dong Pharmaceutical Co., Ltd., headquartered in South Korea (KR), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges available from the company. As a result, Kwang Dong Pharmaceutical's climate commitments and initiatives remain unclear, and there is no information regarding any emissions inherited from a parent or related organization. The company may be in the early stages of developing its climate strategy or reporting framework, which is common in the pharmaceutical industry as companies increasingly focus on sustainability and carbon reduction. In summary, Kwang Dong Pharmaceutical Co., Ltd. has yet to disclose its carbon emissions or specific climate commitments, highlighting a potential area for future development in environmental accountability.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Kwang Dong Pharmaceutical Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
